Yogi Jashnani
Yogi Jashnani
Chief Executive Officer

Yogi Jashnani has served as our Chief Executive Officer since January 7, 2025. Mr. Jashnani has over 20 years of experience in the aesthetics, retail and finance industries. Prior to joining the Company, Mr. Jashnani served as Chief Revenue Officer for Sky Zone. From 2019 through 2023, he served as Chief Commercial Officer of Ideal Image. From fiscal 2017 through 2019, Mr. Jashnani held the position of SVP, Marketing, Insights and Analytics of Advance Auto Parts. Prior to this, Mr. Jashnani was Vice President at Capital One. Mr. Jashnani holds a Masters of Science in Biomedical Engineering and a Masters of Science in Electrical Engineering from University of Wisconsin-Madison. He also holds a Bachelors of Engineering in Telecommunications Engineering for University of Mumbai.

SHOW BIO HIDE BIO
Adam Feinstein
Adam Feinstein

He founded Vesey Street Capital Partners, L.L.C. (VSCP) in 2014 and has 25 years of experience working with many of the leading healthcare services companies. He is currently Chairman of the Board of Directors of HealthChannels, a provider of medical scribe support and value-based healthcare solutions, and Quality Metric, a provider of health and disease specific surveys. He also serves as a member of the Board of Directors of Pathgroup, a leading pathology services company. Prior to founding VSCP, Mr. Feinstein was the Senior Vice President of Corporate Development, Strategic Planning and Office of the Chief Executive Officer at LabCorp. Prior to LabCorp, Mr. Feinstein served as the Managing Director in Equity Research at Barclays Capital/Lehman Brothers and was ranked #1 in the Institutional Investor All America Research Survey in the Health Care Facilities category for eight years. Mr. Feinstein is a CFA Charterholder and holds a B.S. in Business from the Smith School at the University of Maryland.

SHOW BIO HIDE BIO
Daniel Sollof
Daniel Sollof
Daniel Sollof has served as a member of our board of directors since October 2018. Mr. Sollof joined VSCP in August 2014 and serves as a General Partner for the firm. In addition to sourcing and evaluating potential investment opportunities, Mr. Sollof works closely with VSCP’s portfolio companies. He has been a Board Observer at HealthChannels (ScribeAmerica) since October 2016. From July 2015 to August 2017, he served as a member of the Board of Directors of Imedex, Inc. Prior to joining VSCP, Mr. Sollof served as Vice President and Research Analyst for Barclays Capital/Lehman Brothers August 2007 to August 2014,focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Prior to Barclays Capital/Lehman Brothers, Mr. Sollof worked as a Valuation and Business Modeling Analyst in the Transaction Advisory Services group at Ernst & Young from September 2005 to July 2007. Mr. Sollof received a B.S. in Management Science from the University of California – San Diego and is a CFA charterholder.
SHOW BIO HIDE BIO
Caroline Chu
Caroline Chu
Caroline Chu has served as a member of our board of directors since September 2021. Prior to joining the Company, Ms. Chu served as Managing Director for Alwyne Management LP from May 2018 to January 2020. Ms. Chu also served as Investment Analyst, Portfolio Manager, and Managing Director for the Goldman Sachs Group, Inc. from June 2002 to February 2018. Ms. Chu received her B.S. in Economics and Management Science from the Massachusetts Institute of Technology.
SHOW BIO HIDE BIO
Thomas Aaron
Thomas Aaron

Thomas Aaron has served as a member of our Board since October 2021. Mr. Aaron served as a member of the board of directors of Cincinnati Financial Corporation (Nasdaq: CINF), as a member of CINF’s audit committee, as a member of CINF’s compensation committee, and as a member of the boards of directors of CINF’s property casualty insurance companies and other subsidiaries from November 2019 to November 2024. From 2016 to 2017, Mr. Aaron served as Senior Vice President of Finance of Community Health Systems, Inc. (NYSE: CYH). Mr. Aaron was appointed to serve as Executive Vice President and Chief Financial Officer of CYH in May 2017, a position in which he served through December 2019. Prior to joining CYH, Mr. Aaron had a distinguished, 32-year career at Deloitte leading audit and consulting services to, among others, national healthcare organizations. Mr. Aaron is a Certified Public Accountant and holds a B.S. in Accounting from the University of Kentucky.

SHOW BIO HIDE BIO
Kenneth Higgins
Kenneth Higgins
Kenneth Higgins will become a member of our board of directors upon consummation of this offering. Mr. Higgins currently serves as the managing director and co-founder of Northborne Partners, LLC, a middle market-focused mergers and acquisitions advisory firm. Previously, Mr. Higgins spent 4.5 years at BMO Capital Markets Corp. (a subsidiary of Bank of Montreal (NYSE: BMO)) from 2016 to 2021. Mr. Higgins received his Bachelor of Business Administration from the University of Michigan School of Business and his Juris Doctor degree from Harvard Law School.
SHOW BIO HIDE BIO
Michael Doyle
Michael Doyle

Michael Doyle is the non-executive Chairman of our Board of Directors. He has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners, where he led the organization for approximately 15 years and helped to scale it from 3 to over 175 locations. Mr. Doyle has served as Chairman of Orthopedic Solutions Management, a leading orthopedic physician organization, since September 2021, and as Chairman of North America Dental Group since June 2020. He has also served from August 2019 to August 2025 as Chairman of GastroMD, a leading gastroenterologist organization, and from October 2018 to September 2021 as a member of the board of managers of Elite Body Sculpture, the predecessor of the Company prior to its initial public offering.

SHOW BIO HIDE BIO

Board Diversity Matrix

Based upon voluntary self-identification by each member of our Board of Directors, the table below sets forth the diversity composition of our Board of Directors. Each of the categories listed in the table below has the meaning set forth in Nasdaq Rule 5605(f).

Board Diversity Matrix (As of January 7, 2025)*
Total Number of Directors7  
Part I: Gender IdentityFemaleMale  
Directors16  
Part II: Demographic Background
Asian11  
White 5  

 *Inapplicable categories omitted.

Board Diversity Matrix (As of August 8, 2024)*
Total Number of Directors 7
Part I: Gender Identity Female Male
Directors 2 5
Part II: Demographic Background
Asian 1  
White 1 5
LGBTQ+ 1
*Inapplicable categories omitted.